Fenge Li

6PUBLICATIONS
17CO-AUTHORS
Neural engineeringInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 19, 2026
Genetic Engineering of Tumor-Infiltrating Lymphocytes (TIL) via a T-Editor Platform to Enhance Anti-Tumor Activity.

|Jan 04, 2026
Single-Cell Dissection of Tumor-Infiltrating Lymphocytes Reveals Cellular Architecture Predictive of Therapeutic Efficacy in Acral Melanoma.

Chao Zhang, Wanyi Xiao, Hongru Shen

|Jan 15, 2024
Autologous Tumor-Infiltrating Lymphocyte Mono-Therapy Can Rapidly Shrank Tumor in Asian Patient with Stage III/IV Cervical Cancer: Two Cases Report.

Fenge Li, Yupeng Wang, Jin Yan

|Sep 28, 2021
Evolution of CD8+ T Cell Receptor (TCR) Engineered Therapies for the Treatment of Cancer.

Yimo Sun, Fenge Li, Heather Sonnemann

|Jul 10, 2021
Neoantigen vaccination induces clinical and immunologic responses in non-small cell lung cancer patients harboring EGFR mutations.

Fenge Li, Ligang Deng, Kyle R Jackson

|Mar 31, 2021
Association of tumor mutation burden and epidermal growth factor receptor inhibitor history with survival in patients with metastatic stage III/IV non-small-cell lung cancer: A retrospective study.

Yan Lan, Shuo Zhou, Weihong Feng

Pageof 1

Frequent Collaborators

1 joint publications

Yan Lan

1 joint publications

Shuo Zhou

1 joint publications

Weihong Feng

1 joint publications

Ying Qiao